Literature DB >> 11470776

Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines.

K M Paulsson1, P Wang, P O Anderson, S Chen, R F Pettersson, S Li.   

Abstract

In this study we have compared the interaction of human MHC class I molecules with IgG heavy chain (HC) binding protein (BiP), calnexin, calreticulin, tapasin and TAP in beta(2)-microglobulin (beta(2)m)- or TAP-deficient cells, as well as in wild-type B-LCL cells. Distinct differences between the association of HC and these endoplasmic reticulum (ER) proteins were found in the three cell lines. In the absence of beta(2)m (Daudi cells), HC associated with both BiP and calnexin. A prominent portion of HC was complexed simultaneously to both chaperones, as indicated by co-precipitation with either anti-calnexin or anti-class I antisera. In the presence of beta(2)m, but absence of TAP (T2 cells), HC could be co-precipitated with calnexin, whereas no detectable interaction with BiP could be demonstrated. This suggests that calnexin interacts with HC at a later stage than BiP. In B-LCL cells, HC-beta(2)m associated with calreticulin and tapasin, whereas no interaction with calnexin and BiP was observed. In the absence of beta(2)m, HC were rapidly degraded in the ER, while the ER retained HC were stabilized in the presence of beta(2)m, even in the absence of TAP. The dissociation of class I molecules from TAP in B-LCL cells correlated with the kinetics of appearance of class I molecules on the cell surface, suggesting that TAP retains peptide-free class I molecules in the ER. Taken together, our results suggest the model that BiP and calnexin sequentially control the folding of MHC class I, before MHC class I molecules associate with the loading complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470776     DOI: 10.1093/intimm/13.8.1063

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Separate roles and different routing of calnexin and ERp57 in endoplasmic reticulum quality control revealed by interactions with asialoglycoprotein receptor chains.

Authors:  Zehavit Frenkel; Marina Shenkman; Maria Kondratyev; Gerardo Z Lederkremer
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

2.  Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits.

Authors:  Antony N Antoniou; Stuart Ford; Elizabeth S Pilley; Neil Blake; Simon J Powis
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

3.  Hepatitis C virus modulates signal peptide peptidase to alter host protein processing.

Authors:  Junki Hirano; Sachiyo Yoshio; Yusuke Sakai; Li Songling; Tatsuya Suzuki; Yumi Itoh; He Zhang; David Virya Chen; Saori Haga; Hiroko Oomori; Takahiro Kodama; Yusuke Maeda; Yoshihiro Ono; Yu Takahashi; Daron M Standley; Masahiro Yamamoto; Kohji Moriishi; Kyoji Moriya; Tatsuya Kanto; Tetsuo Takehara; Kazuhiko Koike; Yoshiharu Matsuura; Toru Okamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

Review 4.  Understanding the complex mechanisms of β2-microglobulin amyloid assembly.

Authors:  Timo Eichner; Sheena E Radford
Journal:  FEBS J       Date:  2011-06-13       Impact factor: 5.542

5.  The relationship between Helicobacter pylori and beta-2 microglobulin in humans.

Authors:  Abdullah Özgür Yeniova; Metin Kucukazman; Naim Ata; Kursat Dal; Ayşe Kefeli; Sebahat Başyiğit; Bora Aktaş; Kadir Okhan Akın; Yaşar Nazlıgül
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

6.  Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2-microglobulin.

Authors:  Manuela Leri; Francesco Bemporad; Reinier Oropesa-Nuñez; Claudio Canale; Martino Calamai; Daniele Nosi; Matteo Ramazzotti; Sofia Giorgetti; Francesco S Pavone; Vittorio Bellotti; Massimo Stefani; Monica Bucciantini
Journal:  J Cell Mol Med       Date:  2016-03-18       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.